UniProt ID | EXOC8_HUMAN | |
---|---|---|
UniProt AC | Q8IYI6 | |
Protein Name | Exocyst complex component 8 | |
Gene Name | EXOC8 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 725 | |
Subcellular Localization | Cytoplasm . Cytoplasm, perinuclear region . Cell projection, growth cone . Cell projection . Perinuclear in undifferentiated PC12 cells. Redistributes to growing neurites and growth cones during neuronal differentiation (By similarity). Binds lipids | |
Protein Description | Component of the exocyst complex involved in the docking of exocytic vesicles with fusion sites on the plasma membrane.. | |
Protein Sequence | MAMAMSDSGASRLRRQLESGGFEARLYVKQLSQQSDGDRDLQEHRQRIQALAEETAQNLKRNVYQNYRQFIETAREISYLESEMYQLSHLLTEQKSSLESIPLTLLPAAAAAGAAAASGGEEGVGGAGGRDHLRGQAGFFSTPGGASRDGSGPGEEGKQRTLTTLLEKVEGCRHLLETPGQYLVYNGDLVEYDADHMAQLQRVHGFLMNDCLLVATWLPQRRGMYRYNALYSLDGLAVVNVKDNPPMKDMFKLLMFPESRIFQAENAKIKREWLEVLEDTKRALSEKRRREQEEAAAPRGPPQVTSKATNPFEDDEEEEPAVPEVEEEKVDLSMEWIQELPEDLDVCIAQRDFEGAVDLLDKLNHYLEDKPSPPPVKELRAKVEERVRQLTEVLVFELSPDRSLRGGPKATRRAVSQLIRLGQCTKACELFLRNRAAAVHTAIRQLRIEGATLLYIHKLCHVFFTSLLETAREFEIDFAGTDSGCYSAFVVWARSAMGMFVDAFSKQVFDSKESLSTAAECVKVAKEHCQQLGDIGLDLTFIIHALLVKDIQGALHSYKEIIIEATKHRNSEEMWRRMNLMTPEALGKLKEEMKSCGVSNFEQYTGDDCWVNLSYTVVAFTKQTMGFLEEALKLYFPELHMVLLESLVEIILVAVQHVDYSLRCEQDPEKKAFIRQNASFLYETVLPVVEKRFEEGVGKPAKQLQDLRNASRLIRVNPESTTSVV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
6 | Phosphorylation | --MAMAMSDSGASRL --CCCCCCCHHHHHH | 21.06 | 23401153 | |
8 | Phosphorylation | MAMAMSDSGASRLRR CCCCCCCHHHHHHHH | 29.02 | 23401153 | |
11 | Phosphorylation | AMSDSGASRLRRQLE CCCCHHHHHHHHHHH | 35.06 | 28857561 | |
19 | Phosphorylation | RLRRQLESGGFEARL HHHHHHHHCCEEEEE | 53.46 | 30266825 | |
29 | Ubiquitination | FEARLYVKQLSQQSD EEEEEHHHHHHHCCC | 31.78 | 22817900 | |
32 | Phosphorylation | RLYVKQLSQQSDGDR EEHHHHHHHCCCCCH | 24.55 | 24275569 | |
35 | Phosphorylation | VKQLSQQSDGDRDLQ HHHHHHCCCCCHHHH | 35.60 | 23312004 | |
60 | Methylation | EETAQNLKRNVYQNY HHHHHHHHHHHHHHH | 49.85 | - | |
60 | Ubiquitination | EETAQNLKRNVYQNY HHHHHHHHHHHHHHH | 49.85 | 21906983 | |
64 | Phosphorylation | QNLKRNVYQNYRQFI HHHHHHHHHHHHHHH | 8.45 | 27642862 | |
67 | Phosphorylation | KRNVYQNYRQFIETA HHHHHHHHHHHHHHH | 7.11 | 28348404 | |
73 | Phosphorylation | NYRQFIETAREISYL HHHHHHHHHHHHHHH | 26.63 | 27251275 | |
78 | Phosphorylation | IETAREISYLESEMY HHHHHHHHHHHHHHH | 20.93 | 27251275 | |
79 | Phosphorylation | ETAREISYLESEMYQ HHHHHHHHHHHHHHH | 21.83 | 27251275 | |
82 | Phosphorylation | REISYLESEMYQLSH HHHHHHHHHHHHHHH | 25.68 | 27251275 | |
118 | Phosphorylation | AAGAAAASGGEEGVG HHHHHHHHCCCCCCC | 42.47 | 28348404 | |
141 | Phosphorylation | RGQAGFFSTPGGASR CCCCCCCCCCCCCCC | 31.28 | 22199227 | |
142 | Phosphorylation | GQAGFFSTPGGASRD CCCCCCCCCCCCCCC | 22.31 | 25159151 | |
147 | Phosphorylation | FSTPGGASRDGSGPG CCCCCCCCCCCCCCC | 33.89 | 29978859 | |
151 | Phosphorylation | GGASRDGSGPGEEGK CCCCCCCCCCCHHHC | 46.21 | 22985185 | |
161 | Phosphorylation | GEEGKQRTLTTLLEK CHHHCHHCHHHHHHH | 26.43 | 30622161 | |
163 | Phosphorylation | EGKQRTLTTLLEKVE HHCHHCHHHHHHHCC | 18.13 | 28122231 | |
164 | Phosphorylation | GKQRTLTTLLEKVEG HCHHCHHHHHHHCCC | 32.24 | 27067055 | |
168 | Ubiquitination | TLTTLLEKVEGCRHL CHHHHHHHCCCCHHH | 45.62 | - | |
227 | Phosphorylation | QRRGMYRYNALYSLD CCCCCCCCCCEEECC | 6.31 | 32142685 | |
231 | Phosphorylation | MYRYNALYSLDGLAV CCCCCCEEECCCEEE | 12.55 | 32142685 | |
232 | Phosphorylation | YRYNALYSLDGLAVV CCCCCEEECCCEEEE | 22.34 | 28122231 | |
248 | Ubiquitination | VKDNPPMKDMFKLLM CCCCCCHHHHHHHHH | 52.38 | 29967540 | |
268 | Ubiquitination | IFQAENAKIKREWLE HCCCHHHHHCHHHHH | 61.41 | 24816145 | |
270 | Ubiquitination | QAENAKIKREWLEVL CCHHHHHCHHHHHHH | 43.49 | - | |
280 | Phosphorylation | WLEVLEDTKRALSEK HHHHHHHHHHHHHHH | 17.04 | 20860994 | |
281 | Ubiquitination | LEVLEDTKRALSEKR HHHHHHHHHHHHHHH | 48.25 | 29967540 | |
305 | Phosphorylation | PRGPPQVTSKATNPF CCCCCCCCCCCCCCC | 21.18 | 27251275 | |
306 | Phosphorylation | RGPPQVTSKATNPFE CCCCCCCCCCCCCCC | 22.80 | 27251275 | |
307 | Ubiquitination | GPPQVTSKATNPFED CCCCCCCCCCCCCCC | 50.27 | 29967540 | |
309 | Phosphorylation | PQVTSKATNPFEDDE CCCCCCCCCCCCCCC | 47.35 | 27251275 | |
329 | Sumoylation | VPEVEEEKVDLSMEW CCCCHHHHCCCCHHH | 44.31 | - | |
362 | Ubiquitination | GAVDLLDKLNHYLED HHHHHHHHHHHHHCC | 51.67 | 29967540 | |
370 | Ubiquitination | LNHYLEDKPSPPPVK HHHHHCCCCCCCCHH | 37.71 | 29967540 | |
372 | Phosphorylation | HYLEDKPSPPPVKEL HHHCCCCCCCCHHHH | 56.64 | 28985074 | |
377 | Ubiquitination | KPSPPPVKELRAKVE CCCCCCHHHHHHHHH | 57.73 | 29967540 | |
399 | Phosphorylation | EVLVFELSPDRSLRG HHEEEECCCCCCCCC | 19.98 | 24719451 | |
416 | Phosphorylation | KATRRAVSQLIRLGQ HHHHHHHHHHHHHCH | 20.48 | 18452278 | |
426 | Ubiquitination | IRLGQCTKACELFLR HHHCHHHHHHHHHHH | 59.68 | - | |
441 | Phosphorylation | NRAAAVHTAIRQLRI CHHHHHHHHHHHHHH | 19.72 | 23403867 | |
455 | Phosphorylation | IEGATLLYIHKLCHV HCHHHHHHHHHHHHH | 12.23 | - | |
481 | Phosphorylation | FEIDFAGTDSGCYSA HCCCEECCCCCCHHH | 24.46 | 22210691 | |
483 | Phosphorylation | IDFAGTDSGCYSAFV CCEECCCCCCHHHHH | 30.51 | 22210691 | |
511 | Phosphorylation | FSKQVFDSKESLSTA HHHHHHCCHHHHHHH | 27.19 | - | |
512 | Ubiquitination | SKQVFDSKESLSTAA HHHHHCCHHHHHHHH | 53.84 | 29967540 | |
514 | Phosphorylation | QVFDSKESLSTAAEC HHHCCHHHHHHHHHH | 31.21 | - | |
516 | Phosphorylation | FDSKESLSTAAECVK HCCHHHHHHHHHHHH | 25.86 | - | |
517 | Phosphorylation | DSKESLSTAAECVKV CCHHHHHHHHHHHHH | 34.87 | - | |
523 | Ubiquitination | STAAECVKVAKEHCQ HHHHHHHHHHHHHHH | 48.40 | 33845483 | |
567 | Ubiquitination | EIIIEATKHRNSEEM HHHHHHHCCCCHHHH | 47.84 | 29967540 | |
661 | Phosphorylation | AVQHVDYSLRCEQDP HHHHCCHHHCCCCCH | 12.60 | 24719451 | |
679 | Phosphorylation | AFIRQNASFLYETVL HHHHHCHHHHHHHHH | 24.27 | 28348404 | |
699 | Ubiquitination | RFEEGVGKPAKQLQD HHHCCCCCCHHHHHH | 39.12 | 29967540 | |
702 | Ubiquitination | EGVGKPAKQLQDLRN CCCCCCHHHHHHHHH | 61.13 | 24816145 | |
711 | Phosphorylation | LQDLRNASRLIRVNP HHHHHHCHHCEECCC | 31.04 | 30631047 | |
720 | Phosphorylation | LIRVNPESTTSVV-- CEECCCCCCCCCC-- | 37.94 | 30631047 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of EXOC8_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of EXOC8_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of EXOC8_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-142, AND MASSSPECTROMETRY. |